| Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy R Tang, Y Wei, Y Li, W Chen, H Chen, Q Wang, F Yang, Q Miao, X Xiao, ... Gut 67 (3), 534-541, 2018 | 435 | 2018 |
| YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma J Hou, H Zhang, J Liu, Z Zhao, J Wang, Z Lu, B Hu, J Zhou, Z Zhao, ... Molecular cancer 18, 1-17, 2019 | 273 | 2019 |
| Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity XY Li, AK Moesta, C Xiao, K Nakamura, M Casey, H Zhang, J Madore, ... Cancer discovery 9 (12), 1754-1773, 2019 | 225 | 2019 |
| A genome-wide association study identifies six novel risk loci for primary biliary cholangitis F Qiu, R Tang, X Zuo, X Shi, Y Wei, X Zheng, Y Dai, Y Gong, L Wang, ... Nature communications 8 (1), 14828, 2017 | 161 | 2017 |
| The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications J Hou, H Zhang, B Sun, M Karin Journal of hepatology 72 (1), 167-182, 2020 | 153 | 2020 |
| Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis Q Miao, Z Bian, R Tang, H Zhang, Q Wang, S Huang, X Xiao, L Shen, ... Clinical reviews in allergy & immunology 48, 226-235, 2015 | 117 | 2015 |
| The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis F Yang, Q Wang, Z Wang, Q Miao, X Xiao, R Tang, X Chen, Z Bian, ... Clinical reviews in allergy & immunology 50, 114-123, 2016 | 91 | 2016 |
| The role of NK cells and CD39 in the immunological control of tumor metastases H Zhang, D Vijayan, XY Li, SC Robson, N Geetha, MWL Teng, MJ Smyth Oncoimmunology 8 (6), e1593809, 2019 | 83 | 2019 |
| A functional characteristic of cysteine‐rich protein 61: modulation of myeloid‐derived suppressor cells in liver inflammation H Zhang, M Lian, J Zhang, Z Bian, R Tang, Q Miao, Y Peng, J Fang, Z You, ... Hepatology 67 (1), 232-246, 2018 | 49 | 2018 |
| The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury H Zhang, Y Liu, Z Bian, S Huang, X Han, Z You, Q Wang, D Qiu, Q Miao, ... Journal of autoimmunity 53, 55-66, 2014 | 47 | 2014 |
| Clinical and histological features of autoantibody‐negative autoimmune hepatitis in C hinese patients: A single center experience QX Wang, WJ Jiang, Q Miao, X Xiao, HY Zhang, SS Huang, L Shen, ... Journal of Digestive Diseases 14 (4), 175-180, 2013 | 44 | 2013 |
| Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease Z Bian, Q Miao, W Zhong, H Zhang, Q Wang, Y Peng, X Chen, C Guo, ... Journal of autoimmunity 63, 76-87, 2015 | 43 | 2015 |
| Therapeutic potential of IL‐17‐mediated signaling pathway in autoimmune liver diseases H Zhang, F Bernuzzi, A Lleo, X Ma, P Invernizzi Mediators of inflammation 2015 (1), 436450, 2015 | 43 | 2015 |
| Geoepidemiology, genetic and environmental risk factors for PBC H Zhang, M Carbone, A Lleo, P Invernizzi Digestive diseases 33 (Suppl. 2), 94-101, 2015 | 39 | 2015 |
| Quantitation of the rank-rankl axis in primary biliary cholangitis A Lleo, Z Bian, H Zhang, Q Miao, F Yang, Y Peng, X Chen, R Tang, ... PLoS One 11 (9), e0159612, 2016 | 33 | 2016 |
| How the biliary tree maintains immune tolerance? H Zhang, PSC Leung, ME Gershwin, X Ma Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 28 | 2018 |
| A Common Variant in CLDN14 is Associated with Primary Biliary Cirrhosis and Bone Mineral Density R Tang, Y Wei, Z Li, H Chen, Q Miao, Z Bian, H Zhang, Q Wang, Z Wang, ... Scientific reports 6 (1), 19877, 2016 | 26 | 2016 |
| The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid‐Derived Suppressor Cell Activation in Immunoglobulin G4–Related Sclerosing Cholangitis M Lian, Q Wang, X Jiang, J Zhang, Y Wei, Y Li, B Li, W Chen, H Zhang, ... Hepatology 68 (5), 1922-1936, 2018 | 15 | 2018 |
| Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response MZ Qiu, C Wang, Z Wu, Q Zhao, Z Zhao, CY Huang, W Wu, LQ Yang, ... Signal Transduction and Targeted Therapy 8 (1), 370, 2023 | 12 | 2023 |
| Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells Z Lyu, B Huang, J Zhang, Q Qian, X Pu, N Cui, Y Ou, B Li, Z You, M Lian, ... Journal of Autoimmunity 135, 102993, 2023 | 12 | 2023 |
